Matthew Salihi, CEO of Touch Biotechnology says early detection at home can ease pressure on hospitals, reduce wait times, and help families manage flu, RSV and COVID-19 before symptoms escalate.
Matthew Salihi, CEO of Touch Biotechnology says early detection at home can ease pressure on hospitals, reduce wait times, and help families manage flu, RSV and COVID-19 before symptoms escalate.